Enzyme for converting ginsenoside CK into ginsenoside F1 as well as preparation method and application of enzyme

The catalyzing the conversion of ginseng saponin CK into F1 by fermenting bacteria of Bacillus subtilis subtilis, solving the problems of low conversion rate and many intermediate products in the prior art, achieving an efficient and highly selective preparation process, and obtaining high-purity ginseng with high purity Saponin F1.

CN118909986APending Publication Date: 2024-11-08SANYI TECH (GUANGZHOU) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411058766.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-02
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

In the preparation of ginsenoside F1, the conversion rate is low and it is difficult to obtain high purity, with many intermediate products, high separation cost, and lack of efficient methods for converting ginsenoside CK into F1.

Method used

Using Bacillus subtilis subtilis fermentation species, the production enzyme was activated by the isopropanol/water mixture solution inducer of ginsenoside Re, Rg1 and Rg2, catalyzing the hydroxyl group at the 6-O-position and directly converting it into Ginseng saponin F1 avoids glycosyl hydrolysis to produce intermediate products.

Benefits of technology

The efficient conversion rate reached 93.72%, strong selectivity, simplified the subsequent separation process, and obtained high-purity ginseng saponin F1.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909986A_ABST
    Figure CN118909986A_ABST
Patent Text Reader

Abstract

The invention provides an enzyme for converting ginsenoside CK into ginsenoside F1 and a preparation method and application of the enzyme. Bacillus subtillis subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Subsp. Under the catalytic action of the enzyme, ginsenoside CK can be efficiently converted into ginsenoside F1, no intermediate product is generated, the post-treatment process is simple and efficient, the conversion rate is high, and the selectivity is strong; therefore, a new way and a new method are provided for preparing the ginsenoside F1.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of active substance preparation, and in particular to an enzyme for converting ginsenoside CK into ginsenoside F1, and a preparation method and application thereof. Background Art

[0002] Ginseng is well-known for its multifunctionality and multi-target, which mainly depends on its saponin components. Natural active ginsenosides are mainly tetracyclic triterpenoid dammarane saponins, which are divided into two categories: diols and triols. With the deepening of research, scholars have found that these natural ginsenosides containing 3-4 sugar groups are not structures that directly exert their medicinal effects. These components need to be metabolized into secondary ginsenosides with 1-2 sugar groups in the body before they are absorbed and exert their effects. However, this conversion rate in the body is very low, which results in insufficient drug utilization. Therefore, converting polysaccharide saponins into low-sugar saponins in vitro has always been a hot topic of research.

[0003] In the past, the preparation was based on the use of hydrolytic enzymes to cut off the sugar groups. For example, in the preparation of the triol rare ginsenoside F1, Re, R1, and Rg1 were used as substrates to hydrolyze the sugar groups one by one and convert them into F1. However, there were often intermediate products in the middle, and it was difficult to convert all of them into terminal products. The cost of later separation was high, and it was difficult to obtain high-purity F1. The diol saponin CK, which is similar to F1 in structure, also has a glucose group at 20-O-. The only difference in structure is a hydroxyl group at the 6-O-position. If a hydroxyl group can be connected to the 6-C-position of CK, F1 can be generated. Due to the characteristics of the structures of the two, there are no other intermediate products between them. There are currently no reports on this type of conversion. Summary of the invention

[0004] The present application provides an enzyme for converting ginsenoside CK into ginsenoside F1 and a preparation method and application thereof to solve the problems existing in the related technologies. The technical solution is as follows:

[0005] In the first aspect, the embodiments of the present application provide an enzyme for converting ginsenoside CK into ginsenoside F1, wherein the enzyme is obtained by using Bacillus subtilis subsp. subtilis as a fermentation strain, through seed production, expansion culture, activation of enzyme production, and extraction;

[0006] The activation of enzyme production uses an inducer; the inducer is an isopropanol / water mixed solution of ginsenoside Re, Rg1 and Rg2.

[0007] In one embodiment, the mass ratio of the ginsenosides Re, Rg1 and Rg2 is 1:(1-2):(0.5-1).

[0008] In one embodiment, the mass ratio of isopropanol to water is 1:(3-10); the total mass of the isopropanol and water is 10-20 times the total mass of ginsenosides.

[0009] In one embodiment, the seed production is achieved in a seed culture medium, and the seed culture medium includes the following components in parts by weight:

[0010] 5-20 parts of glucose, 3-10 parts of soluble starch, 10-20 parts of peptone, 1-3 parts of sodium chloride, 1-5 parts of potassium chloride, 0.1-1 parts of beef extract and 800-1200 parts of water.

[0011] In one embodiment, the culture conditions are:

[0012] The temperature of the seed culture is 28-30° C., and the time of the seed culture is 3-5 days.

[0013] In one embodiment, the expansion culture is carried out in a fermentation medium, and the fermentation medium comprises the following components by weight:

[0014] 10-20 parts of glucose, 3-10 parts of soluble starch, 10-20 parts of peptone, 1-3 parts of sodium chloride, 1-5 parts of potassium chloride, 0.1-1 parts of beef extract, 5-15 parts of isopropanol, 5-15 parts of butanediol and 800-1200 parts of water.

[0015] In one embodiment, the enzyme production process is activated by adding the inducer to the fermentation medium, and the amount of the inducer added is 3-8% of the mass of the fermentation medium.

[0016] In one embodiment, the conditions of the expansion process are: fermentation culture at 34-38° C. for 12-48 hours.

[0017] In one embodiment, the conditions for activating the enzyme production process are: fermentation culture at 34-38° C. for 24-48 hours.

[0018] In one embodiment, the extraction steps are: after enzyme production is completed, centrifuge to remove the bacteria; add 35%-50% saturation ammonium sulfate to the supernatant and let it stand; separate the solid and liquid to obtain the precipitate, which is the enzyme that converts ginsenoside CK into ginsenoside F1.

[0019] In a second aspect, an embodiment of the present application provides a method for converting ginsenoside CK into ginsenoside F1, characterized in that ginsenoside CK is used as a raw material and the enzyme for converting ginsenoside CK into ginsenoside F1 is used as a catalyst for the conversion reaction.

[0020] In one embodiment, the conversion reaction is carried out in a solution, wherein the solution is a citric acid buffer solution with a pH of 6.0 and a concentration of 0.1 M; the mass ratio of ginsenoside CK to the buffer solution is 1:(20-100).

[0021] In one embodiment, the mass ratio of ginsenoside CK to enzyme is 1:(0.4-2).

[0022] In one embodiment, the reaction conditions are: reaction at 40-50° C. for 12-72 h.

[0023] In one embodiment, the conversion reaction includes a post-treatment step:

[0024] After solid-liquid separation, the precipitate is recrystallized by ethanol to obtain the ginsenoside F1.

[0025] The advantages or beneficial effects of the above technical solution include at least:

[0026] The present application discloses an enzyme for converting ginsenoside CK into ginsenoside F1, which is obtained by fermentation culture with Bacillus subtilis subsp. subtilis as a fermentation bacterium under an inducer. Under the catalytic action of the enzyme, a hydroxyl group can be connected to the 6-O-position of ginsenoside CK, thereby efficiently converting ginsenoside CK into ginsenoside F1, which provides a new route and method for preparing ginsenoside F1. The conversion reaction process catalyzed by the enzyme will not affect the sugar group, so no intermediate product is produced, and the conversion rate is high, reaching 93.72%, and the selectivity is strong; therefore, after the conversion reaction is completed, pure ginsenoside F1 can be obtained by simple post-treatment.

[0027] The above summary is for illustrative purposes only and is not intended to be limiting in any way. In addition to the illustrative aspects, embodiments and features described above, further aspects, embodiments and features of the present application will be readily apparent by reference to the accompanying drawings and the following detailed description. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] In the accompanying drawings, unless otherwise specified, the same reference numerals throughout the multiple drawings represent the same or similar parts or elements. These drawings are not necessarily drawn to scale. It should be understood that these drawings only depict some embodiments disclosed in the present application and should not be regarded as limiting the scope of the present application.

[0029] Figure 1 The enzyme SDS-polyacrylamide gel electrophoresis diagram of the transformed ginsenoside CK prepared in this application into ginsenoside F1;

[0030] Figure 2 The molecular weight of the purified enzyme is calculated using standard proteins;

[0031] Figure 3 The HPLC chromatogram of the reaction solution after 6 hours of conversion reaction in Example 1;

[0032] Figure 4The HPLC chromatogram of the reaction solution after 12 hours of conversion reaction in Example 1;

[0033] Figure 5 The HPLC diagram of the reaction solution after 36 h of the conversion reaction in Example 1. DETAILED DESCRIPTION

[0034] In the following, only some exemplary embodiments are briefly described. As those skilled in the art will appreciate, the described embodiments may be modified in various ways without departing from the spirit or scope of the present application. Therefore, the drawings and descriptions are considered to be exemplary and non-restrictive in nature.

[0035] The 20-O- of ginsenoside F1 has a glucose group, and a hydroxyl group is connected to the 6-O-position; when preparing ginsenoside F1 in the prior art, a 20-O- with a glucose group and one or two Rg1, Re or R1 connected to the 6-O-position is often used as a substrate, and the sugar groups connected to the 6-O-position of the substrate are hydrolyzed one by one to prepare ginsenoside F1. However, the sugar group carried by 20-O- may also be hydrolyzed, and when two sugar groups are connected to the 6-O-position, incomplete hydrolysis will also result in the failure to obtain ginsenoside F1 and the production of by-products. The above-mentioned raw materials and intermediates are similar in structure to ginsenoside F1, and due to the difficulty in separating various saponins, it is difficult to obtain pure ginsenoside F1; the application of ginsenoside F1 is limited. Therefore, in response to the above problems, the present application provides an enzyme for converting ginsenoside CK into ginsenoside F1, and its preparation method and application.

[0036] The present application embodiment provides an enzyme for converting ginsenoside CK into ginsenoside F1, wherein the enzyme is obtained by using Bacillus subtilis subsp. subtilis as a fermentation strain, through seed production, expansion culture, activation of enzyme production, and extraction;

[0037] The activation of enzyme production uses an inducer; the inducer is an isopropanol / water mixed solution of ginsenoside Re, Rg1 and Rg2.

[0038] The present application uses an inducer to activate Bacillus subtilis subspecies subtilis to ferment and produce enzymes. The obtained enzyme is different from the hydrolase and plays a role in hydrolyzing and removing the glycoside; it will not affect the glycoside and can connect a hydroxyl group at the 6-O-position of the saponin. It is used to transform ginsenoside CK into ginsenoside F1, on the one hand, avoiding the intermediates produced by the hydrolysis of the glycoside, and on the other hand, efficiently preparing the synthetic ginsenoside F1.

[0039] In one embodiment, the mass ratio of ginsenoside Re, Rg1 and Rg2 is 1:(1-2):(0.5-1). Ginsenoside Re, Rg1 and Rg2 are used as direct inducers to bind to the activation elements in the bacterial cells, activate the transcription and translation of genes, and express specific enzymes. The applicant tried a variety of different inducer combinations, but only under the induction of the combination of ginsenoside Re, Rg1 and Rg2 of the applicant, the enzyme produced by Bacillus subtilis subtilis can specifically convert ginsenoside CK into ginsenoside F1.

[0040] In one embodiment, the mass ratio of isopropanol to water is 1:(3-10); the total mass of the isopropanol and water is 10-20 times the total mass of ginsenosides.

[0041] Isopropanol has strong permeability and can affect the normal functions of enzymes, coenzymes and intermediate metabolites in the bacteria, so it is used to assist the induction of the inducer on Bacillus subtilis subtilis. It should be noted that high concentrations of isopropanol have a killing effect on bacteria, so in this application, the mass concentration of isopropanol in the aqueous solution is 10%-33.3%, and it is added to the fermentation medium containing a large amount of water, which will not kill Bacillus subtilis subtilis.

[0042] In one embodiment, the seed production is achieved in a seed culture medium, and the seed culture medium includes the following components in parts by weight:

[0043] 5-20 parts of glucose, 3-10 parts of soluble starch, 10-20 parts of peptone, 1-3 parts of sodium chloride, 1-5 parts of potassium chloride, 0.1-1 parts of beef extract and 800-1200 parts of water.

[0044] In one embodiment, the culture conditions are:

[0045] The temperature of the seed culture is 28-30° C., and the time of the seed culture is 3-5 days.

[0046] In the seed culture medium process, the bacteria grow rapidly, providing seeds with strong vitality for the subsequent fermentation process.

[0047] In one embodiment, the expansion culture is carried out in a fermentation medium, and the fermentation medium comprises the following components by weight:

[0048] 10-20 parts of glucose, 3-10 parts of soluble starch, 10-20 parts of peptone, 1-3 parts of sodium chloride, 1-5 parts of potassium chloride, 0.1-1 parts of beef extract, 5-15 parts of isopropanol, 5-15 parts of butanediol and 800-1200 parts of water.

[0049] In one embodiment, the enzyme production process is activated by adding the inducer to the fermentation medium, and the amount of the inducer added is 3-8% of the mass of the fermentation medium.

[0050] In one embodiment, the conditions of the expansion process are: fermentation culture at 34-38° C. for 12-48 hours.

[0051] In one embodiment, the conditions for activating the enzyme production process are: fermentation culture at 34-38° C. for 24-48 hours.

[0052] The mature bacteria are obtained by expansion culture. The amount of the inducer added is 3-8% of the mass of the fermentation medium. Excessive addition of the inducer will inhibit the activity of the strain, so the application sets the amount of the inducer added to 3-8% of the mass of the fermentation medium.

[0053] In one embodiment, the extraction steps are: after enzyme production is completed, centrifuge to remove the bacteria; add 35%-50% saturation ammonium sulfate to the supernatant and let it stand; separate the solid and liquid to obtain the precipitate, which is the enzyme that converts ginsenoside CK into ginsenoside F1.

[0054] After removing the bacteria, the enzyme is precipitated by salting out. The separation method is simple and can obtain a relatively pure enzyme.

[0055] The embodiment of the present application also provides a method for converting ginsenoside CK into ginsenoside F1, characterized in that ginsenoside CK is used as a raw material and the enzyme for converting ginsenoside CK into ginsenoside F1 is used as a catalyst for the conversion reaction.

[0056] The only structural difference between ginsenoside CK and ginsenoside F1 is the hydroxyl group at the 6-O-position. Therefore, when converting ginsenoside CK to ginsenoside F1, the reaction only takes place at the 6-O-position, which can reduce the occurrence of side reactions and reduce the difficulty of separating subsequent products.

[0057] In one embodiment, the conversion reaction is carried out in a solution, wherein the solution is a citric acid buffer solution with a pH of 6.0 and a concentration of 0.1 M; the mass ratio of ginsenoside CK to the buffer solution is 1:(20-100). The citric acid buffer solution provides a stable weakly acidic condition for the activity of the enzyme.

[0058] In one embodiment, the mass ratio of ginsenoside CK to enzyme is 1:(0.4-2). The amount of enzyme added is not less than 40% of the substrate ginsenoside CK; therefore, ginsenosides are poorly water-soluble, so a large amount of aqueous solution is required for dispersion, and the reaction is carried out in a large amount of solution. If the amount of enzyme added is too low, the reaction efficiency is low.

[0059] In one embodiment, the reaction conditions are: 40-50° C. for 12-72 hours. The appropriate temperature can maintain the activity of the enzyme.

[0060] In one embodiment, the conversion reaction includes a post-treatment step:

[0061] After solid-liquid separation, the precipitate is recrystallized by ethanol to obtain the ginsenoside F1. In the present application, ginsenosides are suspended in a buffer solution, so ginsenosides can be separated by solid-liquid separation methods such as centrifugation and filtration. The present application has high conversion rate and selectivity, so the separated precipitate is basically ginsenoside F1.

[0062] In one embodiment, ginsenoside CK and a buffer solution are first mixed and homogenized to form a suspension; the enzyme is dissolved in the buffer solution; and then the two liquids are mixed and reacted.

[0063] The following is a further description with reference to a specific implementation method.

[0064] Example 1

[0065] An enzyme for converting ginsenoside CK into ginsenoside F1 and a preparation method thereof, comprising the following steps:

[0066] Bacillus subtilis subsp. subtilis (strain number: CICC10066) was inoculated into a seed culture medium and cultured in a shaker at a speed of 100-120 rpm and a culture condition of 28-30° C. for 4 days to obtain seeds; the seed culture medium composition was 15 g glucose, 5 g soluble starch, 15 g peptone, 2 g sodium chloride, 3 g potassium chloride, 0.5 g beef extract, and 1000 g water;

[0067] The prepared Bacillus subtilis seeds are inoculated into a fermentation medium at an inoculation rate of 3.5%, and the fermentation medium contains 15g glucose, 5g soluble starch, 15g peptone, 2g sodium chloride, 3g potassium chloride, 0.5g beef extract, 10g isopropanol, 10g butanediol, and 1000g water; the culture is carried out at 34-38 for 12-48h. 6% enzyme activator of the mass of the culture medium is added to the fermentation tank, and the fermentation culture is continued at 34-38°C for 24-48h. The enzyme activator includes, by weight, 1 part of ginsenoside Re, 1.5 parts of ginsenoside Rg1, 0.75 parts of ginsenoside Rg2, 8 parts of isopropanol, and 41 parts of water.

[0068] After the fermentation is completed, the bacteria are removed by centrifugation to obtain a supernatant; ammonium sulfate with a saturation of 40% is added to the obtained supernatant, and the mixture is centrifuged. The precipitate is retained to obtain an enzyme that converts ginsenoside CK into ginsenoside F1.

[0069] Example 2

[0070] An enzyme for converting ginsenoside CK into ginsenoside F1 and a preparation method thereof, comprising the following steps:

[0071] Bacillus subtilis subsp. subtilis (strain number: CICC10066) was inoculated into a seed culture medium and cultured in a shaker at a speed of 100-120 rpm and a culture condition of 28-30° C. for 3 days to obtain seeds; the seed culture medium composition was 5 g glucose, 10 g soluble starch, 10 g peptone, 3 g sodium chloride, 1 g potassium chloride, 0.1 g beef extract, and 1200 g water;

[0072] The prepared Bacillus subtilis seeds are inoculated into a fermentation medium at an inoculation rate of 5%, and the fermentation medium contains 5g glucose, 10g soluble starch, 10g peptone, 3g sodium chloride, 1g potassium chloride, 0.1g beef extract, 5g isopropanol, 15g butanediol, and 1200g water; the culture is carried out at 34-38 for 12-48h. 3% enzyme activator of the mass of the culture medium is added to the fermentation tank, and the fermentation culture is continued at 34-38°C for 24-48h. The enzyme activator includes, by weight, 1 part of ginsenoside Re, 1 part of ginsenoside Rg1, 1 part of ginsenoside Rg2, 7.5 parts of isopropanol, and 22.5 parts of water.

[0073] After the fermentation is completed, the bacteria are removed by centrifugation to obtain a supernatant; ammonium sulfate with a saturation of 35% is added to the obtained supernatant, and the mixture is centrifuged. The precipitate is retained to obtain an enzyme that converts ginsenoside CK into ginsenoside F1.

[0074] Example 3

[0075] An enzyme for converting ginsenoside CK into ginsenoside F1 and a preparation method thereof, comprising the following steps:

[0076] Bacillus subtilis subsp. subtilis (strain number: CICC10066) was inoculated into a seed culture medium and cultured in a shaker at a speed of 100-120 rpm and a culture condition of 28-30° C. for 5 days to obtain seeds; the seed culture medium composition was 20 g glucose, 3 g soluble starch, 20 g peptone, 1 g sodium chloride, 5 g potassium chloride, 1 g beef extract, and 800 g water;

[0077] The prepared Bacillus subtilis seeds are inoculated into a fermentation medium at an inoculation rate of 2%, and the fermentation medium contains 20g glucose, 3g soluble starch, 20g peptone, 1g sodium chloride, 5g potassium chloride, 0.5g beef extract, 15g isopropanol, 5g butanediol, and 800g water; the culture is carried out at 34-38 for 12-48h. An enzyme activator of 8% of the mass of the culture medium is added to the fermentation tank, and the fermentation culture is continued at 34-38°C for 24-48h. The enzyme activator includes, by weight, 1 part of ginsenoside Re, 2 parts of ginsenoside Rg1, 0.5 parts of ginsenoside Rg2, 9.5 parts of isopropanol, and 95.5 parts of water.

[0078] After the fermentation is completed, the bacteria are removed by centrifugation to obtain a supernatant; ammonium sulfate with a saturation of 50% is added to the obtained supernatant, and the mixture is centrifuged. The precipitate is retained to obtain an enzyme that converts ginsenoside CK into ginsenoside F1.

[0079] Enzyme purification: DEAE-Cellulose DE52 was used to separate and purify the enzyme that converted ginsenoside CK prepared in the example into ginsenoside F1.

[0080] Take 5 mL of the converted ginsenoside CK prepared in Example 1 as the enzyme wet column for ginsenoside F1, and after all the enzyme proteins are adsorbed by the column, first rinse the column with 0.02 mol / L acetic acid-sodium acetate buffer at pH = 5.0 to remove unadsorbed impurities such as sugar and salt and protein, and then elute with 0.02 mol / L acetic acid-sodium acetate buffer at pH = 5.0 with a KCl concentration of 20-150 mmol / L, collect the eluate, detect the enzyme activity and its purity, and finally find a high-purity enzyme.

[0081] Then, the purity and molecular weight were tested by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). The standard proteins (markers) used were: phosphatase b (97.2 kDa), bovine serum albumin (66.4 kDa), ovalbumin (44.3 kDa), carbonic acid glycosides (29.0 kDa), trypsin inhibitor (20.1 kDa), lysozyme (14.3 kDa). The SDS-polyacrylamide gel electrophoresis diagram is shown in the attached figure. Figure 1 As shown in the figure, the molecular weight of the purified transaminase can be calculated based on the molecular weight and mobility of the standard protein, which is about 37.2 kDa. Figure 2 shown.

[0082] Example 4

[0083] A method for converting ginsenoside CK into ginsenoside F1, comprising the following specific steps:

[0084] The enzyme for converting ginsenoside CK into ginsenoside F1 prepared in Example 1 was dissolved in a citric acid buffer solution at pH 6.0 and a concentration of 0.1 M to obtain an enzyme solution, wherein the mass ratio of the enzyme to the buffer solution was 1:20; ginsenoside CK was mixed with a 0.1 M citric acid buffer solution at pH 6.0 and homogenized to obtain a substrate suspension, wherein the mass ratio of the saponin to the buffer solution was 1:20.

[0085] The enzyme solution and substrate suspension were mixed at a mass ratio of 1:1, and reacted at 45°C for 36 hours; stirred during the reaction at a speed of 200-250rpm; after the reaction, centrifuged, collected the precipitate, dissolved it with an appropriate amount of ethanol, centrifuged to remove the insoluble matter, and evaporated to dryness to obtain ginsenoside F1; the conversion process is as follows:

[0086]

[0087] Example 5

[0088] A method for converting ginsenoside CK into ginsenoside F1, comprising the following specific steps:

[0089] The enzyme for converting ginsenoside CK into ginsenoside F1 prepared in Example 1 was dissolved in a citric acid buffer solution at pH 6.0 and a concentration of 0.1 M to obtain an enzyme solution, and the mass ratio of the enzyme to the buffer solution was 1:5; ginsenoside CK was mixed with a 0.1 M citric acid buffer solution at pH 6.0, and homogenized to obtain a substrate suspension, and the mass ratio of ginsenoside CK to the buffer solution was 1:10.

[0090] The enzyme solution and substrate suspension were mixed at a mass ratio of 2:1, and reacted at 40°C for 72 hours; stirred during the reaction at a speed of 200-250rpm; after the reaction, centrifuged, collected the precipitate, dissolved it with an appropriate amount of ethanol, centrifuged to remove the insoluble matter, and evaporated to dryness to obtain ginsenoside F1.

[0091] Example 6

[0092] A method for converting ginsenoside CK into ginsenoside F1, comprising the following specific steps:

[0093] The enzyme for converting ginsenoside CK into ginsenoside F1 prepared in Example 1 was dissolved in a citric acid buffer solution with a pH value of 6.0 and a concentration of 0.1 M to obtain an enzyme solution, wherein the mass ratio of the enzyme to the buffer solution was 1:50; ginsenoside CK was mixed with a 0.1 M citric acid buffer solution with a pH value of 6.0, and the mixture was homogenized to obtain a substrate suspension, wherein the mass ratio of the saponin to the buffer solution was 2.5:50.

[0094] The enzyme solution and the substrate suspension were mixed in a mass ratio of 1:1, and reacted at 45°C for 36 hours; stirred during the reaction at a speed of 200-250rpm; after the reaction, centrifuged, collected the precipitate, dissolved it with an appropriate amount of ethanol, centrifuged to remove the insoluble matter, and evaporated to dryness to obtain ginsenoside F1.

[0095] Comparative Example 1

[0096] The difference from Example 4 is that the enzyme for converting ginsenoside CK into ginsenoside F1 prepared in Example 1 is not added; other conditions are the same.

[0097] Comparative Example 2

[0098] According to the method for preparing the enzyme in Example 1, Aspergillus parasiticus (strain number: CICC2003) was cultured under the same conditions to obtain the corresponding enzyme, and the prepared enzyme was used to transform ginsenoside CK according to the method in Example 4.

[0099] Comparative Example 3

[0100] According to the preparation method of the enzyme in Example 1, the inducer is calculated by weight: 1 part of ginsenoside Rd, 1.5 parts of ginsenoside R1, 0.75 parts of ginsenoside Rh, 8 parts of isopropanol, and 41 parts of water; the corresponding enzyme is obtained, and the prepared enzyme is used to transform ginsenoside CK according to the method of Example 4.

[0101] In the preparation process of Example 4, samples were taken at 6h, 12h, and 36h of the reaction and the samples were subjected to HPLC detection. The results are as follows: Figure 3-5 (In order to make the image size appropriate, only the part after retention time 32 minutes is shown in the figure) and as shown in Table 1-3, where Figure 3 The liquid phase diagram of the reaction solution after 6 h of reaction, Table 1 is the data; Figure 4 The liquid phase diagram of the reaction solution after 12 h of reaction, and the data are shown in Table 2; Figure 5 The liquid phase diagram of the reaction solution after 36 hours of reaction is shown in Table 3.

[0102] Table 1

[0103] name Retention time area %area 1 F1 45.137 4123236 30.81 2 CK 59.466 9261516 69.19

[0104] Table 2

[0105] name Retention time area %area 1 F1 45.187 8535146 56.75 2 CK 59.450 6504428 43.25

[0106] Table 3

[0107] name Retention time area %area 1 F1 45.101 1860372 93.72 2 CK 59.418 124755 6.28

[0108] From the data in Table 1-3, we can know that 30% of ginsenoside CK was converted after 6 hours of reaction, and no substances other than ginsenoside CK and ginsenoside F1 were detected in the liquid phase test. All ginsenoside CK was converted into ginsenoside F1. After 12 hours of reaction, 56% of ginsenoside CK was converted into ginsenoside F1. After 36 hours of reaction, 93.72% of ginsenoside CK was converted into ginsenoside F1, reflecting super high conversion rate and selectivity.

[0109] The products after the conversion reaction of Comparative Examples 1-3 were sampled and the samples were subjected to HPLC detection. The results of HPLC detection were that no new peaks appeared in the chromatograms, and no ginsenoside F1 was generated, indicating that ginsenoside CK was not converted. This also shows that if the enzyme of the present application is not added in Comparative Example 1, ginsenoside CK will not change; other strains are used to prepare enzymes in Comparative Example 2, and the prepared enzymes do not have a corresponding effect on ginsenoside CK; in Comparative Example 3, the saponin type of the inducer is changed, and the enzyme produced does not play a role in the conversion of ginsenoside CK.

[0110] In summary, the present invention discloses an enzyme for converting ginsenoside CK into ginsenoside F1, which is obtained by fermentation culture with Bacillus subtilis subspecies subtilis as a fermentation bacterium under an inducer; under the catalytic action of the enzyme, a hydroxyl group can be connected to the 6-O-position of ginsenoside CK, thereby efficiently converting ginsenoside CK into ginsenoside F1, which provides a new route and method for preparing ginsenoside F1. The conversion reaction process catalyzed by the enzyme will not affect the sugar group, so no intermediate product is produced, and the conversion rate is high, reaching 93.72%, and the selectivity is strong; therefore, after the conversion reaction is completed, pure ginsenoside F1 can be obtained by simple post-treatment.

[0111] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present application. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine different embodiments or examples described in this specification and the features of different embodiments or examples, unless they are contradictory.

[0112] In addition, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Therefore, a feature defined as "first" or "second" may explicitly or implicitly include at least one of the features. In the description of this application, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined.

[0113] The above is only a specific implementation of the present application, but the protection scope of the present application is not limited thereto. Any technician familiar with the technical field can easily think of various changes or substitutions within the technical scope disclosed in the present application, which should be included in the protection scope of the present application. Therefore, the protection scope of the present application should be based on the protection scope of the claims.

Claims

1. An enzyme for converting ginsenoside CK into ginsenoside F1, characterized in that: The enzyme is obtained by using Bacillus subtilis subsp. subtilis as fermentation strain through seed production, expansion culture, enzyme activation and extraction; The activation of enzyme production uses an inducer; the inducer is an isopropanol / water mixed solution of ginsenoside Re, Rg1 and Rg2.

2. The enzyme for converting ginsenoside CK into ginsenoside F1 according to claim 1, characterized in that: The mass ratio of the ginsenosides Re, Rg1 and Rg2 is 1:(1-2):(0.5-1); The mass ratio of isopropanol to water is 1:(3-10); The total mass of the isopropanol and water is 10-20 times the total mass of ginsenosides.

3. The enzyme for converting ginsenoside CK into ginsenoside F1 according to claim 1 or 2, characterized in that: The seed production is achieved in a seed culture medium, which includes the following components in parts by weight: 5-20 parts of glucose, 3-10 parts of soluble starch, 10-20 parts of peptone, 1-3 parts of sodium chloride, 1-5 parts of potassium chloride, 0.1-1 parts of beef extract and 800-1200 parts of water; The culture conditions are: The temperature of the seed culture is 28-30° C., and the time of the seed culture is 3-5 days.

4. The enzyme for converting ginsenoside CK into ginsenoside F1 according to claim 1, characterized in that: The expansion culture is carried out in a fermentation medium, which comprises the following components by weight: 10-20 parts of glucose, 3-10 parts of soluble starch, 10-20 parts of peptone, 1-3 parts of sodium chloride, 1-5 parts of potassium chloride, 0.1-1 parts of beef extract, 5-15 parts of isopropanol, 5-15 parts of butanediol and 800-1200 parts of water.

5. The enzyme for converting ginsenoside CK into ginsenoside F1 according to claim 1, characterized in that: The process of activating enzyme production is to add the inducer into the fermentation medium, and the amount of the inducer added is 3-8% of the mass of the fermentation medium.

6. The enzyme for converting ginsenoside CK into ginsenoside F1 according to claim 1, characterized in that: The conditions of the expansion process are: fermentation culture at 34-38°C for 12-48h; The conditions for activating the enzyme production process are: fermentation and cultivation at 34-38°C for 24-48 hours.

7. The enzyme for converting ginsenoside CK into ginsenoside F1 according to claim 1, characterized in that: The extraction steps are as follows: after the enzyme production is completed, the bacteria are removed by centrifugation; 35%-50% saturation ammonium sulfate is added to the supernatant and allowed to stand; solid-liquid separation is performed to obtain a precipitate, which is the enzyme that converts ginsenoside CK into ginsenoside F1.

8. A method for converting ginsenoside CK into ginsenoside F1, characterized in that: Ginsenoside CK is used as a raw material, and the enzyme for converting ginsenoside CK into ginsenoside F1 according to any one of claims 1 to 7 is used as a catalyst for the conversion reaction.

9. The method for converting ginsenoside CK into ginsenoside F1 according to claim 8, characterized in that: The conversion reaction is carried out in a solution, wherein the solution is a citric acid buffer solution with a pH of 6.0 and a concentration of 0.1 M; The mass ratio of ginsenoside CK to buffer is 1:(20-100); The mass ratio of ginsenoside CK to enzyme is 1:(0.4-2); The reaction conditions are: reaction at 40-50°C for 12-72h.

10. The method for converting ginsenoside CK into ginsenoside F1 according to claim 8, characterized in that: The conversion reaction includes post-processing steps: After solid-liquid separation, the precipitate is recrystallized by ethanol to obtain the ginsenoside F1.